Background: Facing the diversity of omics data and the difficulty of selecting one result over all those produced by several methods, consensus strategies have the potential to reconcile multiple inputs and to produce robust results. Results: Here, we introduce ClustOmics, a generic consensus clustering tool that we use in the context of cancer subtyping. ClustOmics relies on a non-relational graph database, which allows for the simultaneous integration of both multiple omics data and results from various clustering methods. This new tool conciliates input clusterings, regardless of their origin, their number, their size or their shape. ClustOmics implements an intuitive and flexible strategy, based upon the idea of evidence accumulation cl...
Single-cell RNA-seq enables the quantitative characterization of cell types based on global transcri...
Extensive amounts of multi-omics data and multiple cancer subtyping methods have been developed rapi...
It is now clear that major malignancies are heterogeneous diseases associated with diverse molecular...
International audienceBackground: Facing the diversity of omics data and the difficulty of selecting...
Disease subtyping, which helps to develop personalized treatments, remains a challenge in data analy...
Abstract Background The Cancer Genome Atlas (TCGA) has collected transcriptome, genome and epigenome...
Advances in high-throughput technologies allow for measurements of many types of omics data, yet the...
Comprehensive molecular characterization of cancer subtypes is essential for predicting clinical out...
Abstract Background To ensure cancer patients are stratified towards treatments that are optimally b...
Finding subtypes of heterogeneous diseases is the biggest challenge in the area of biology. Often, c...
The remarkable growth of multi-platform genomic profiles has led to the challenge of multiomics data...
Typical clustering analysis for large-scale genomics data combines two unsupervised learning techniq...
Summary: Cancer is an extremely complex disease and each type of cancer usually has several differen...
Motivation: In biomedical research a growing number of platforms and technologies are used to measur...
With the rapid advancement of high-throughput technologies, a large amount of high-dimensional omics...
Single-cell RNA-seq enables the quantitative characterization of cell types based on global transcri...
Extensive amounts of multi-omics data and multiple cancer subtyping methods have been developed rapi...
It is now clear that major malignancies are heterogeneous diseases associated with diverse molecular...
International audienceBackground: Facing the diversity of omics data and the difficulty of selecting...
Disease subtyping, which helps to develop personalized treatments, remains a challenge in data analy...
Abstract Background The Cancer Genome Atlas (TCGA) has collected transcriptome, genome and epigenome...
Advances in high-throughput technologies allow for measurements of many types of omics data, yet the...
Comprehensive molecular characterization of cancer subtypes is essential for predicting clinical out...
Abstract Background To ensure cancer patients are stratified towards treatments that are optimally b...
Finding subtypes of heterogeneous diseases is the biggest challenge in the area of biology. Often, c...
The remarkable growth of multi-platform genomic profiles has led to the challenge of multiomics data...
Typical clustering analysis for large-scale genomics data combines two unsupervised learning techniq...
Summary: Cancer is an extremely complex disease and each type of cancer usually has several differen...
Motivation: In biomedical research a growing number of platforms and technologies are used to measur...
With the rapid advancement of high-throughput technologies, a large amount of high-dimensional omics...
Single-cell RNA-seq enables the quantitative characterization of cell types based on global transcri...
Extensive amounts of multi-omics data and multiple cancer subtyping methods have been developed rapi...
It is now clear that major malignancies are heterogeneous diseases associated with diverse molecular...